| Age groups, years |
---|
40.0–44.9 | 45.0–49.9 | 50.0–54.9 | 55.0–59.9 | 60.0–64.9 | 65.0–69.9 | 70.0–74.9 | ≥ 75.0 |
---|
EPIC study |
ER+ | 30 | 88 | 152 | 189 | 227 | 239 | 233 | 186 |
ER− | 19 | 35 | 44 | 43 | 42 | 41 | 40 | 31 |
WHI study |
ER+ | – | – | 126 | 173 | 185 | 237 | 243 | 270 |
ER− | – | – | 48 | 50 | 43 | 50 | 39 | 50 |
- Hazards are presented as number of tumors per 105 person-years
- EPIC European Prospective Investigation into Cancer and Nutrition, WHI Women’s Health Initiative, ER estrogen receptor
- aRisk factor profiles for baseline hazard: country = France (only for EPIC), menopausal status = 1 (postmenopausal), age at menopause ≤ 45 years, duration of breastfeeding = 0, age at menarche ≤ 11 years, duration of hormone replacement therapy = 0, full-term pregnancy = 0 (nulliparous), body mass index < 25 kg/m2, height_d10 (body height in cm divided by 10) = 16, alcohol intake (drinks/day) = 0